WebCSL BEHRING My Source CSL Behring Patient Assistance Program Stimate (desmopressin acetate) CONTACT INFO: Address:, Phone: 1-844-727-2752: Provider Phone: Fax: Website: Program Website: ELIGIBILITY ... WebAug 11, 2024 · Ferring Pharmaceuticals issued a voluntary recall of Stimate (desmopressin) nasal spray due to “superpotency” – in other words, amounts of desmopressin being …
STIMATE Patient Assistance Program
WebOur Focus on Serious & Rare Diseases. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and … For over a year now, STIMATE® has been unavailable to patients, creating hardship. In July of 2024, Ferring Pharmaceuticals and CSL Behring first announced a pharmacy level recall. Patient concerns continued when, in February 2024, Ferring Pharmaceuticals stated that it did not anticipate restarting … See more The nation’s leading advocacy organizations for the inheritable blood disorders community — HFA, NHF, and the Hemophilia Alliance — are united in their concern about … See more With the prospect of a product absence extending well into 2024, NHF, HFA, and the Hemophilia Alliance have successfully petitioned the U.S. Food and Drug Administration to add … See more Patients should, in the meantime, reach out to medical professionals with any personal treatment concerns. Please note that HFA, NHF, and … See more dusit thani lakeview cairo facebook
CSL Behring Publishes Design for First-Ever Outcomes Study of …
Webto inform you that the Stimate distribution agreement between CSL Behring and Ferring has ended. For all questions relating to Stimate, please contact Ferring at 1-888-FERRING (1-888-337-7464) – option #2 or Email: [email protected]. Our commitment to patient care and the bleeding disorder community remains a key priority and guiding ... WebJul 3, 2024 · The sabbatical is an outgrowth of CSL Behring’s partnership with Penn State to nurture the next generation of biotech professionals. The goal of the partnership is twofold: to establish a state-of-the-art Center of Excellence in Industrial Biotechnology at Penn State, which opened in 2024, and to develop a multidisciplinary biotech curriculum ... WebThe Penn State and CSL Behring partnership began in 2024 when CSL Behring gifted the university $4.92M to create the Center of Excellence in Industrial Biotechnology (CoEIB) and the CSL Behring Fermentation Facility. The collaboration was designed to create an environment to provide educational, experiential and research opportunities for ... duwic.fr